Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study.
Michihiro IwakiTakaomi KessokuKosuke TanakaAnna OzakiYuki KasaiAtsushi YamamotoKota TakahashiTakashi KobayashiAsako NogamiYasushi HondaYuji OgawaKento ImajoMasato YonedaNoritoshi KobayashiSatoru SaitoHirokazu TakahashiPublished in: BMJ open (2022)
V.1.1, 19 August 2021.